Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

NOVEL RETRIEVAL METHOD FOR STUDYING CANCER PROTEINS

7/16/2010

Interview with W. Andy Tao, Ph.D., Assistant Professor, Analytical Chemistry and Chemical Biology, Purdue University

A Purdue University researcher says he can better retrieve specific proteins needed to study how cancer cells form by using a newly developed technique and a synthetic nanopolymer. Dr. W. Andy Tao notes that while such phosphoproteins can be mapped and analyzed to find ways to inhibit the processes that lead to cancer those few proteins first must be fished out of a sea of thousands of other proteins.


During this week’s podcast Dr. Tao discusses his polymer-based metal-ion affinity capture method for retrieving phosphoproteins. He talks about studies that have demonstrated the usefulness of the technique and points out its advantages over other methods for working with phosphoproteins.


Dr. Tao also looks at other applications for the novel methodology and tells GEN about future plans for his team’s research.

Dr. W. Andy Tao received his Ph.D. education in Professor R. Graham Cooks’ premier mass spectrometry group in 2001 and postdoctoral training in systems biology in Professors Leroy Hood and Ruedi Aebersold’s groups from 2002–2004. He is currently an associate professor in the departments of biochemistry, chemistry, and medicinal chemistry & molecular pharmacology at Purdue University. His research group has focused on mass spectrometry-based proteomic research and, in particular, has pioneered the development of soluble nanopolymers as a novel platform for protein modifications at the proteome scale.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll